Products
New therapy approved for control of canine atopic dermatitis
January 1st 2004Veterinarians now have a safe and effective non-steroidal option for long-term control of canine atopic dermatitis. Atopica, which contains the active ingredient cyclosporine A (CsA), has been approved by the U.S. Food and Drug Administration (FDA) for Novartis Animal Health.